nodes	percent_of_prediction	percent_of_DWPC	metapath
Bendroflumethiazide—CA2—osteoporosis	0.62	1	CbGaD
Bendroflumethiazide—CA2—Zoledronate—osteoporosis	0.238	1	CbGbCtD
Bendroflumethiazide—CA4—Erythrocytes take up carbon dioxide and release oxygen—CA2—osteoporosis	0.00691	0.167	CbGpPWpGaD
Bendroflumethiazide—CA1—Erythrocytes take up carbon dioxide and release oxygen—CA2—osteoporosis	0.00635	0.154	CbGpPWpGaD
Bendroflumethiazide—CA4—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.00549	0.133	CbGpPWpGaD
Bendroflumethiazide—CA1—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.00504	0.122	CbGpPWpGaD
Bendroflumethiazide—Epigastric discomfort—Calcitriol—osteoporosis	0.00295	0.0311	CcSEcCtD
Bendroflumethiazide—Gastric irritation—Conjugated Estrogens—osteoporosis	0.00281	0.0297	CcSEcCtD
Bendroflumethiazide—Urine output increased—Ergocalciferol—osteoporosis	0.00232	0.0245	CcSEcCtD
Bendroflumethiazide—Polyuria—Ergocalciferol—osteoporosis	0.00212	0.0224	CcSEcCtD
Bendroflumethiazide—Epigastric discomfort—Conjugated Estrogens—osteoporosis	0.00207	0.0219	CcSEcCtD
Bendroflumethiazide—Blood disorder—Ibandronate—osteoporosis	0.00189	0.02	CcSEcCtD
Bendroflumethiazide—Drug interaction—Alendronate—osteoporosis	0.00175	0.0185	CcSEcCtD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—ID4—osteoporosis	0.00142	0.0342	CbGpPWpGaD
Bendroflumethiazide—Urine output increased—Calcitriol—osteoporosis	0.0014	0.0148	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Raloxifene—osteoporosis	0.00133	0.0141	CcSEcCtD
Bendroflumethiazide—Polyuria—Calcitriol—osteoporosis	0.00128	0.0135	CcSEcCtD
Bendroflumethiazide—Purpura—Estropipate—osteoporosis	0.00124	0.0131	CcSEcCtD
Bendroflumethiazide—Thirst—Ibandronate—osteoporosis	0.00121	0.0127	CcSEcCtD
Bendroflumethiazide—Cyclothiazide—CA2—osteoporosis	0.0012	0.228	CrCbGaD
Bendroflumethiazide—Benzthiazide—CA2—osteoporosis	0.0012	0.228	CrCbGaD
Bendroflumethiazide—Thirst—Calcitriol—osteoporosis	0.00118	0.0125	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Estropipate—osteoporosis	0.00108	0.0114	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Alendronate—osteoporosis	0.00106	0.0112	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Ibandronate—osteoporosis	0.00103	0.0109	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Estropipate—osteoporosis	0.00101	0.0107	CcSEcCtD
Bendroflumethiazide—Hydroflumethiazide—CA2—osteoporosis	0.001	0.191	CrCbGaD
Bendroflumethiazide—Anorexia—Calcium Acetate—osteoporosis	0.000988	0.0104	CcSEcCtD
Bendroflumethiazide—Hydrochlorothiazide—CA2—osteoporosis	0.000975	0.186	CrCbGaD
Bendroflumethiazide—Hypotension—Calcium Acetate—osteoporosis	0.000969	0.0102	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Calcitriol—osteoporosis	0.000953	0.0101	CcSEcCtD
Bendroflumethiazide—Drug interaction—Estradiol—osteoporosis	0.000941	0.00993	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Calcium Acetate—osteoporosis	0.000901	0.00951	CcSEcCtD
Bendroflumethiazide—Constipation—Calcium Acetate—osteoporosis	0.000886	0.00936	CcSEcCtD
Bendroflumethiazide—Anorexia—Ergocalciferol—osteoporosis	0.000873	0.00921	CcSEcCtD
Bendroflumethiazide—Trichlormethiazide—CA2—osteoporosis	0.000869	0.166	CrCbGaD
Bendroflumethiazide—Thirst—Zoledronate—osteoporosis	0.000864	0.00912	CcSEcCtD
Bendroflumethiazide—Purpura—Conjugated Estrogens—osteoporosis	0.000821	0.00867	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Pamidronate—osteoporosis	0.000819	0.00865	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Pamidronate—osteoporosis	0.00081	0.00855	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Etidronic acid—osteoporosis	0.000802	0.00846	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Ergocalciferol—osteoporosis	0.000796	0.0084	CcSEcCtD
Bendroflumethiazide—Urine output increased—Estradiol—osteoporosis	0.000789	0.00833	CcSEcCtD
Bendroflumethiazide—Constipation—Ergocalciferol—osteoporosis	0.000783	0.00827	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Zoledronate—osteoporosis	0.000748	0.0079	CcSEcCtD
Bendroflumethiazide—Asthenia—Calcium Acetate—osteoporosis	0.000744	0.00785	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Zoledronate—osteoporosis	0.00074	0.00781	CcSEcCtD
Bendroflumethiazide—Polyuria—Estradiol—osteoporosis	0.000721	0.00762	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Conjugated Estrogens—osteoporosis	0.00072	0.0076	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Conjugated Estrogens—osteoporosis	0.000713	0.00752	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Calcium Acetate—osteoporosis	0.000709	0.00749	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Estradiol—osteoporosis	0.000708	0.00748	CcSEcCtD
Bendroflumethiazide—TPMT—Biological oxidations—CYP27A1—osteoporosis	0.000703	0.017	CbGpPWpGaD
Bendroflumethiazide—Muscle spasms—Estropipate—osteoporosis	0.000693	0.00732	CcSEcCtD
Bendroflumethiazide—TPMT—Metapathway biotransformation—CYP27A1—osteoporosis	0.000693	0.0168	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—COL1A2—osteoporosis	0.000691	0.0167	CbGpPWpGaD
Bendroflumethiazide—Dizziness—Calcium Acetate—osteoporosis	0.000685	0.00724	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Alendronate—osteoporosis	0.000683	0.00721	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Raloxifene—osteoporosis	0.000672	0.00709	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Conjugated Estrogens—osteoporosis	0.000671	0.00708	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Ibandronate—osteoporosis	0.000665	0.00702	CcSEcCtD
Bendroflumethiazide—Vomiting—Calcium Acetate—osteoporosis	0.000659	0.00696	CcSEcCtD
Bendroflumethiazide—Purpura—Estradiol—osteoporosis	0.000657	0.00694	CcSEcCtD
Bendroflumethiazide—Asthenia—Ergocalciferol—osteoporosis	0.000657	0.00694	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—WNT1—osteoporosis	0.000628	0.0152	CbGpPWpGaD
Bendroflumethiazide—Nausea—Calcium Acetate—osteoporosis	0.000616	0.0065	CcSEcCtD
Bendroflumethiazide—Constipation—Etidronic acid—osteoporosis	0.000582	0.00614	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Estradiol—osteoporosis	0.00057	0.00602	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.000562	0.00593	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Raloxifene—osteoporosis	0.000558	0.00589	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Risedronate—osteoporosis	0.000548	0.00579	CcSEcCtD
Bendroflumethiazide—Nausea—Ergocalciferol—osteoporosis	0.000544	0.00574	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Estradiol—osteoporosis	0.000537	0.00567	CcSEcCtD
Bendroflumethiazide—Anorexia—Calcitriol—osteoporosis	0.000527	0.00556	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Pamidronate—osteoporosis	0.000521	0.0055	CcSEcCtD
Bendroflumethiazide—Constipation—Estropipate—osteoporosis	0.000503	0.00531	CcSEcCtD
Bendroflumethiazide—Constipation—Alendronate—osteoporosis	0.000496	0.00523	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Ibandronate—osteoporosis	0.000491	0.00518	CcSEcCtD
Bendroflumethiazide—Constipation—Ibandronate—osteoporosis	0.000483	0.0051	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Calcitriol—osteoporosis	0.00048	0.00507	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Zoledronate—osteoporosis	0.000476	0.00502	CcSEcCtD
Bendroflumethiazide—Constipation—Calcitriol—osteoporosis	0.000473	0.00499	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—WDR1—osteoporosis	0.000469	0.0113	CbGpPWpGaD
Bendroflumethiazide—Diarrhoea—Etidronic acid—osteoporosis	0.000466	0.00492	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000458	0.00484	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Pamidronate—osteoporosis	0.000433	0.00457	CcSEcCtD
Bendroflumethiazide—Vomiting—Etidronic acid—osteoporosis	0.000433	0.00457	CcSEcCtD
Bendroflumethiazide—Rash—Etidronic acid—osteoporosis	0.000429	0.00453	CcSEcCtD
Bendroflumethiazide—Dermatitis—Etidronic acid—osteoporosis	0.000429	0.00453	CcSEcCtD
Bendroflumethiazide—Asthenia—Estropipate—osteoporosis	0.000422	0.00446	CcSEcCtD
Bendroflumethiazide—Anorexia—Pamidronate—osteoporosis	0.000422	0.00445	CcSEcCtD
Bendroflumethiazide—Asthenia—Alendronate—osteoporosis	0.000416	0.00439	CcSEcCtD
Bendroflumethiazide—Hypotension—Pamidronate—osteoporosis	0.000413	0.00436	CcSEcCtD
Bendroflumethiazide—Constipation—Ethinyl Estradiol—osteoporosis	0.000408	0.00431	CcSEcCtD
Bendroflumethiazide—Asthenia—Ibandronate—osteoporosis	0.000405	0.00428	CcSEcCtD
Bendroflumethiazide—Nausea—Etidronic acid—osteoporosis	0.000404	0.00427	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Estropipate—osteoporosis	0.000403	0.00425	CcSEcCtD
Bendroflumethiazide—Constipation—Risedronate—osteoporosis	0.000398	0.0042	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Alendronate—osteoporosis	0.000397	0.00419	CcSEcCtD
Bendroflumethiazide—Asthenia—Calcitriol—osteoporosis	0.000396	0.00419	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Zoledronate—osteoporosis	0.000396	0.00418	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Raloxifene—osteoporosis	0.00039	0.00412	CcSEcCtD
Bendroflumethiazide—Dizziness—Estropipate—osteoporosis	0.000389	0.00411	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Ibandronate—osteoporosis	0.000386	0.00408	CcSEcCtD
Bendroflumethiazide—Anorexia—Zoledronate—osteoporosis	0.000385	0.00407	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Pamidronate—osteoporosis	0.000384	0.00406	CcSEcCtD
Bendroflumethiazide—Dizziness—Alendronate—osteoporosis	0.000383	0.00405	CcSEcCtD
Bendroflumethiazide—Constipation—Pamidronate—osteoporosis	0.000378	0.00399	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Calcitriol—osteoporosis	0.000378	0.00399	CcSEcCtD
Bendroflumethiazide—Hypotension—Zoledronate—osteoporosis	0.000377	0.00399	CcSEcCtD
Bendroflumethiazide—Dizziness—Raloxifene—osteoporosis	0.000377	0.00398	CcSEcCtD
Bendroflumethiazide—Vomiting—Estropipate—osteoporosis	0.000374	0.00395	CcSEcCtD
Bendroflumethiazide—Dizziness—Ibandronate—osteoporosis	0.000373	0.00394	CcSEcCtD
Bendroflumethiazide—Rash—Estropipate—osteoporosis	0.000371	0.00392	CcSEcCtD
Bendroflumethiazide—Dermatitis—Estropipate—osteoporosis	0.000371	0.00392	CcSEcCtD
Bendroflumethiazide—Anorexia—Conjugated Estrogens—osteoporosis	0.000371	0.00391	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—CAP1—osteoporosis	0.000371	0.00896	CbGpPWpGaD
Bendroflumethiazide—TPMT—Biological oxidations—CYP19A1—osteoporosis	0.000369	0.00892	CbGpPWpGaD
Bendroflumethiazide—Vomiting—Alendronate—osteoporosis	0.000369	0.00389	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Estradiol—osteoporosis	0.000367	0.00387	CcSEcCtD
Bendroflumethiazide—Rash—Alendronate—osteoporosis	0.000366	0.00386	CcSEcCtD
Bendroflumethiazide—Dermatitis—Alendronate—osteoporosis	0.000365	0.00386	CcSEcCtD
Bendroflumethiazide—TPMT—Metapathway biotransformation—CYP19A1—osteoporosis	0.000364	0.0088	CbGpPWpGaD
Bendroflumethiazide—Hypotension—Conjugated Estrogens—osteoporosis	0.000363	0.00384	CcSEcCtD
Bendroflumethiazide—Vomiting—Raloxifene—osteoporosis	0.000363	0.00383	CcSEcCtD
Bendroflumethiazide—Rash—Raloxifene—osteoporosis	0.00036	0.0038	CcSEcCtD
Bendroflumethiazide—Dermatitis—Raloxifene—osteoporosis	0.000359	0.00379	CcSEcCtD
Bendroflumethiazide—Vomiting—Ibandronate—osteoporosis	0.000359	0.00379	CcSEcCtD
Bendroflumethiazide—Rash—Ibandronate—osteoporosis	0.000356	0.00376	CcSEcCtD
Bendroflumethiazide—Dermatitis—Ibandronate—osteoporosis	0.000356	0.00375	CcSEcCtD
Bendroflumethiazide—Vomiting—Calcitriol—osteoporosis	0.000351	0.00371	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Zoledronate—osteoporosis	0.000351	0.00371	CcSEcCtD
Bendroflumethiazide—Nausea—Estropipate—osteoporosis	0.00035	0.00369	CcSEcCtD
Bendroflumethiazide—Rash—Calcitriol—osteoporosis	0.000348	0.00368	CcSEcCtD
Bendroflumethiazide—Dermatitis—Calcitriol—osteoporosis	0.000348	0.00368	CcSEcCtD
Bendroflumethiazide—Constipation—Zoledronate—osteoporosis	0.000345	0.00365	CcSEcCtD
Bendroflumethiazide—Nausea—Alendronate—osteoporosis	0.000344	0.00364	CcSEcCtD
Bendroflumethiazide—Asthenia—Ethinyl Estradiol—osteoporosis	0.000342	0.00361	CcSEcCtD
Bendroflumethiazide—Nausea—Raloxifene—osteoporosis	0.000339	0.00358	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000338	0.00357	CcSEcCtD
Bendroflumethiazide—Nausea—Ibandronate—osteoporosis	0.000335	0.00354	CcSEcCtD
Bendroflumethiazide—Asthenia—Risedronate—osteoporosis	0.000334	0.00352	CcSEcCtD
Bendroflumethiazide—Constipation—Conjugated Estrogens—osteoporosis	0.000333	0.00351	CcSEcCtD
Bendroflumethiazide—Nausea—Calcitriol—osteoporosis	0.000328	0.00347	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000326	0.00345	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Risedronate—osteoporosis	0.000318	0.00336	CcSEcCtD
Bendroflumethiazide—Asthenia—Pamidronate—osteoporosis	0.000317	0.00335	CcSEcCtD
Bendroflumethiazide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000316	0.00333	CcSEcCtD
Bendroflumethiazide—Dizziness—Risedronate—osteoporosis	0.000308	0.00325	CcSEcCtD
Bendroflumethiazide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000303	0.0032	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Pamidronate—osteoporosis	0.000303	0.00319	CcSEcCtD
Bendroflumethiazide—Rash—Ethinyl Estradiol—osteoporosis	0.000301	0.00318	CcSEcCtD
Bendroflumethiazide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000301	0.00317	CcSEcCtD
Bendroflumethiazide—Vomiting—Risedronate—osteoporosis	0.000296	0.00312	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—MGLL—osteoporosis	0.000295	0.00712	CbGpPWpGaD
Bendroflumethiazide—Rash—Risedronate—osteoporosis	0.000293	0.0031	CcSEcCtD
Bendroflumethiazide—Dermatitis—Risedronate—osteoporosis	0.000293	0.00309	CcSEcCtD
Bendroflumethiazide—Dizziness—Pamidronate—osteoporosis	0.000292	0.00309	CcSEcCtD
Bendroflumethiazide—Asthenia—Zoledronate—osteoporosis	0.00029	0.00306	CcSEcCtD
Bendroflumethiazide—Nausea—Ethinyl Estradiol—osteoporosis	0.000283	0.00299	CcSEcCtD
Bendroflumethiazide—Vomiting—Pamidronate—osteoporosis	0.000281	0.00297	CcSEcCtD
Bendroflumethiazide—Asthenia—Conjugated Estrogens—osteoporosis	0.000279	0.00295	CcSEcCtD
Bendroflumethiazide—Rash—Pamidronate—osteoporosis	0.000279	0.00294	CcSEcCtD
Bendroflumethiazide—Dermatitis—Pamidronate—osteoporosis	0.000279	0.00294	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Zoledronate—osteoporosis	0.000276	0.00292	CcSEcCtD
Bendroflumethiazide—Nausea—Risedronate—osteoporosis	0.000276	0.00292	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Estradiol—osteoporosis	0.000271	0.00286	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—PLEK—osteoporosis	0.000269	0.00651	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—ANXA2—osteoporosis	0.000269	0.00651	CbGpPWpGaD
Bendroflumethiazide—Dizziness—Zoledronate—osteoporosis	0.000267	0.00282	CcSEcCtD
Bendroflumethiazide—Constipation—Estradiol—osteoporosis	0.000266	0.00281	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000266	0.00281	CcSEcCtD
Bendroflumethiazide—Nausea—Pamidronate—osteoporosis	0.000263	0.00277	CcSEcCtD
Bendroflumethiazide—Dizziness—Conjugated Estrogens—osteoporosis	0.000257	0.00272	CcSEcCtD
Bendroflumethiazide—Vomiting—Zoledronate—osteoporosis	0.000257	0.00271	CcSEcCtD
Bendroflumethiazide—Rash—Zoledronate—osteoporosis	0.000255	0.00269	CcSEcCtD
Bendroflumethiazide—Dermatitis—Zoledronate—osteoporosis	0.000254	0.00269	CcSEcCtD
Bendroflumethiazide—Vomiting—Conjugated Estrogens—osteoporosis	0.000247	0.00261	CcSEcCtD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000246	0.00595	CbGpPWpGaD
Bendroflumethiazide—Rash—Conjugated Estrogens—osteoporosis	0.000245	0.00259	CcSEcCtD
Bendroflumethiazide—Dermatitis—Conjugated Estrogens—osteoporosis	0.000245	0.00259	CcSEcCtD
Bendroflumethiazide—Nausea—Zoledronate—osteoporosis	0.00024	0.00253	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—TLN1—osteoporosis	0.000232	0.00561	CbGpPWpGaD
Bendroflumethiazide—Nausea—Conjugated Estrogens—osteoporosis	0.000231	0.00244	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—VCL—osteoporosis	0.000229	0.00554	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Estradiol—osteoporosis	0.000223	0.00236	CcSEcCtD
Bendroflumethiazide—TPMT—Biological oxidations—POMC—osteoporosis	0.000222	0.00536	CbGpPWpGaD
Bendroflumethiazide—Diarrhoea—Estradiol—osteoporosis	0.000213	0.00225	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—FDPS—osteoporosis	0.000209	0.00506	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PKM—osteoporosis	0.000209	0.00506	CbGpPWpGaD
Bendroflumethiazide—Dizziness—Estradiol—osteoporosis	0.000206	0.00217	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—PGLS—osteoporosis	0.000198	0.0048	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GPD2—osteoporosis	0.000198	0.0048	CbGpPWpGaD
Bendroflumethiazide—Vomiting—Estradiol—osteoporosis	0.000198	0.00209	CcSEcCtD
Bendroflumethiazide—Rash—Estradiol—osteoporosis	0.000196	0.00207	CcSEcCtD
Bendroflumethiazide—Dermatitis—Estradiol—osteoporosis	0.000196	0.00207	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—RAP1A—osteoporosis	0.000191	0.00463	CbGpPWpGaD
Bendroflumethiazide—Nausea—Estradiol—osteoporosis	0.000185	0.00195	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—ATIC—osteoporosis	0.000181	0.00439	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PNP—osteoporosis	0.000181	0.00439	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—LEP—osteoporosis	0.000181	0.00438	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—FGA—osteoporosis	0.000174	0.0042	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—ADCY5—osteoporosis	0.000163	0.00393	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—FGB—osteoporosis	0.000158	0.00382	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CA2—osteoporosis	0.000154	0.00373	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—OXCT1—osteoporosis	0.000154	0.00373	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PKM—osteoporosis	0.000151	0.00366	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—FDPS—osteoporosis	0.000151	0.00366	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—MYC—osteoporosis	0.000151	0.00366	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—MGLL—osteoporosis	0.00015	0.00363	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—FDPS—osteoporosis	0.000145	0.00351	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PKM—osteoporosis	0.000145	0.00351	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GPD2—osteoporosis	0.000143	0.00347	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PGLS—osteoporosis	0.000143	0.00347	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PKM—osteoporosis	0.000139	0.00336	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—FDPS—osteoporosis	0.000139	0.00336	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PGLS—osteoporosis	0.000137	0.00332	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GPD2—osteoporosis	0.000137	0.00332	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PGLS—osteoporosis	0.000132	0.00319	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GPD2—osteoporosis	0.000132	0.00319	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ATIC—osteoporosis	0.000131	0.00317	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PNP—osteoporosis	0.000131	0.00317	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—IDH2—osteoporosis	0.000128	0.00309	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PNP—osteoporosis	0.000126	0.00304	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ATIC—osteoporosis	0.000126	0.00304	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ATIC—osteoporosis	0.000121	0.00291	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PNP—osteoporosis	0.000121	0.00291	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP27A1—osteoporosis	0.00012	0.00291	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ACP5—osteoporosis	0.000117	0.00283	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—OXCT1—osteoporosis	0.000112	0.0027	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CA2—osteoporosis	0.000112	0.0027	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MGLL—osteoporosis	0.000109	0.00263	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—TPI1—osteoporosis	0.000109	0.00263	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—OXCT1—osteoporosis	0.000107	0.00258	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—MGLL—osteoporosis	0.000104	0.00252	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—OXCT1—osteoporosis	0.000103	0.00248	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CA2—osteoporosis	0.000103	0.00248	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—P4HB—osteoporosis	0.000102	0.00247	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GAPDH—osteoporosis	0.0001	0.00242	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—MGLL—osteoporosis	9.99e-05	0.00242	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—RAP1A—osteoporosis	9.77e-05	0.00236	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—IDH2—osteoporosis	9.24e-05	0.00223	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ADCY5—osteoporosis	9.23e-05	0.00223	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—IDH2—osteoporosis	8.86e-05	0.00214	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP27A1—osteoporosis	8.69e-05	0.0021	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—IDH2—osteoporosis	8.49e-05	0.00205	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ACP5—osteoporosis	8.45e-05	0.00204	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP27A1—osteoporosis	8.33e-05	0.00201	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ACP5—osteoporosis	8.1e-05	0.00196	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP27A1—osteoporosis	7.99e-05	0.00193	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ENO1—osteoporosis	7.9e-05	0.00191	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—TPI1—osteoporosis	7.86e-05	0.0019	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PSMA5—osteoporosis	7.78e-05	0.00188	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PSMA2—osteoporosis	7.78e-05	0.00188	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ACP5—osteoporosis	7.77e-05	0.00188	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—TPI1—osteoporosis	7.53e-05	0.00182	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—P4HB—osteoporosis	7.39e-05	0.00179	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GAPDH—osteoporosis	7.25e-05	0.00175	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—TPI1—osteoporosis	7.22e-05	0.00175	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—IGF1—osteoporosis	7.15e-05	0.00173	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—P4HB—osteoporosis	7.08e-05	0.00171	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—RAP1A—osteoporosis	7.06e-05	0.00171	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GAPDH—osteoporosis	6.95e-05	0.00168	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—P4HB—osteoporosis	6.79e-05	0.00164	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—RAP1A—osteoporosis	6.77e-05	0.00164	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—IL6—osteoporosis	6.76e-05	0.00163	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GAPDH—osteoporosis	6.67e-05	0.00161	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—RAP1A—osteoporosis	6.49e-05	0.00157	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP19A1—osteoporosis	6.31e-05	0.00153	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ENO1—osteoporosis	5.71e-05	0.00138	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PSMA2—osteoporosis	5.63e-05	0.00136	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PSMA5—osteoporosis	5.63e-05	0.00136	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ENO1—osteoporosis	5.47e-05	0.00132	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PSMA5—osteoporosis	5.39e-05	0.0013	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PSMA2—osteoporosis	5.39e-05	0.0013	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ENO1—osteoporosis	5.25e-05	0.00127	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PSMA2—osteoporosis	5.17e-05	0.00125	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PSMA5—osteoporosis	5.17e-05	0.00125	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ADCY5—osteoporosis	5.16e-05	0.00125	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GPX1—osteoporosis	5.14e-05	0.00124	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—MTHFR—osteoporosis	4.74e-05	0.00115	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP19A1—osteoporosis	4.56e-05	0.0011	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP19A1—osteoporosis	4.38e-05	0.00106	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—TGFB1—osteoporosis	4.29e-05	0.00104	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP19A1—osteoporosis	4.2e-05	0.00101	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—POMC—osteoporosis	3.79e-05	0.000917	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ADCY5—osteoporosis	3.73e-05	0.000902	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GPX1—osteoporosis	3.72e-05	0.000898	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ADCY5—osteoporosis	3.58e-05	0.000864	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GPX1—osteoporosis	3.56e-05	0.000861	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MTHFR—osteoporosis	3.43e-05	0.000829	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ADCY5—osteoporosis	3.43e-05	0.000829	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GPX1—osteoporosis	3.42e-05	0.000826	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—MTHFR—osteoporosis	3.29e-05	0.000795	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—MTHFR—osteoporosis	3.15e-05	0.000762	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—POMC—osteoporosis	2.74e-05	0.000663	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—POMC—osteoporosis	2.63e-05	0.000636	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—POMC—osteoporosis	2.52e-05	0.00061	CbGpPWpGaD
